MAK036
Hemin Assay Kit
sufficient for 100 colorimetric tests
Synonym(s):
Hemin Quantitative Test Kit
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.84
UNSPSC Code:
12161503
usage
sufficient for 100 colorimetric tests
application(s)
cosmetics
food and beverages
detection method
colorimetric
relevant disease(s)
immunological diseases; rheumatological diseases; gastrointestinal diseases; cardiovascular diseases
storage temp.
2-8°C
General description
Hemin, the oxidized version of heme, is an iron-containing prosthetic group for a diverse group of proteins. Free heme, which can be released from hemoglobin following hemolysis, is pro-inflammatory and contributes to iron-derived reactive oxygen species. Free hemin levels may be upregulated in various pathological conditions and can contribute to various inflammatory conditions including vascular disorders, renal failure, and immune-mediated disorders.
Application
Hemin Assay Kit has been used to determine the level of free hemin (oxidized heme).
Suitable for use with cell and tissue culture supernatants, urine, plasma, serum, fecal material, media, and other biological fluids.
Biochem/physiol Actions
In this assay, Hemin concentration is determined by a coupled enzyme reaction, which results in a colorimetric (570 nm) product, proportional to the Hemin present.
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
Storage Class
10 - Combustible liquids
flash_point_f
188.6 °F - closed cup
flash_point_c
87 °C - closed cup
wgk
WGK 3
Regulatory Information
动植物源性产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Laura Casares et al.
Redox biology, 28, 101321-101321 (2019-09-14)
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against different pathologies including skin diseases. However, although the efficacy in preclinical models and the clinical benefits of CBD in humans have been extensively
Characterization of novel inhibition of indoleamine 2, 3-dioxygenase by targeting its apo form.
Ortiz-Meoz R F, et al.
bioRxiv, 324947-324947 (2018)
Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.
Fader K A, et al.
Toxicology and Applied Pharmacology, 321, 1-17 (2017)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| MAK036-1KT | 04061834064855 |